microdosing glp 1 for perimenopause GLP-1 and Menopause: A Hormone-Aware Metabolic Framework Microdosing GLP-1s: A Doctor's Guide

H., Liu, M., Yang, S

Weiduschat, J.W

However, it remains uncertain whether the doses used for diabetes management achieve sufficient central nervous system penetration to produce clinically meaningful neuroprotective effects

CAROLYN BRAMANTE: Yeah, so exactly, that's one of the concerns, especially in older adults, is that weight loss usually goes with losing muscle and fat-- fat tissue

The most commonly reported side effects are mild and temporary, such as slight redness or soreness at the injection site

56,57 Furthermore, there is a focus on developing GLP-1RAs that can be taken orally without the need for injections